Research Tissue Bank for people with Myeloproliferative Disorders (MPD)

What we are studying

We are attempting to better understand the causes of MPD and to develop improved methods for the diagnosis and treatment of these diseases. These diseases carry a high risk of developing leukemia. It is important to continue to learn more about these blood cancers and to learn more about the effectiveness and potential side effects of various treatments. It is our belief that further information about these cancer cells as well as the effects of treatment will lead to the improvement of current therapies and the development of entirely new treatments for these diseases.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Newly diagnosed with:
    • Philadelphia chromosome negative myeloproliferative neoplasms (MPN) polycythemia vera (PV)
  • Primary myelofibrosis (PMF)
  • And essential thrombocythemia (ET)
  • Patients previously treated for an MPN are eligible

What is involved

  • Preservation and/or storage of a small portion of one or more of the following tissues:
  • Whole blood
  • Bone marrow
  • Bone marrow biopsy
  • Spleen cells
  • Toenail clippings

Compensation

None

Contact Information

Study Coordinator
Thomas Freeman, PA-C
Email
thfreema@wakehealth.edu
Phone
336-713-6914

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.